Pawel Namsolleck
Hessische Str. 3-4
Berlin, BE 10115, Germany
Berlin, BE 10115, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma.
Journal: International journal of molecular sciences
Published: May 11, 2023
LP2, a stable lanthipeptide derived from cAng-(1-7), exerts myeloprotective action in mice.
Journal: European journal of haematology
Published: October 11, 2022
LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice.
Journal: Peptides
Published: September 11, 2022
LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study.
Journal: Peptides
Published: September 04, 2020
Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors.
Journal: Biochemical Society transactions
Published: July 19, 2020
Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?
Journal: Molecular medicine (Cambridge, Mass.)
Published: June 27, 2020
AT2R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: July 11, 2018
Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: December 15, 2017
AT2 receptors in cardiovascular and renal diseases.
Journal: Pharmacological research
Published: May 02, 2017
Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MAS.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: November 30, 2016
Last Updated: 09/26/2026